About Us
What we do
We treat a wide range of liver diseases, including fatty liver or NAFLD and NASH, Alcoholic Liver Disease, Cirrhosis, Hepatic Encephalopathy Hepatitis, Hepatitis B, Hepatitis C, Portal Hypertension, Liver Cancer, and more. We also assess patients who need liver transplantation and care for them until the day of the transplant and then continue to follow them afterward. Our institute offers cutting-edge research through the Houston Research Institute. We also offer a free FibroScan®, which quantifies liver fat and fibrosis (Scarring).
(must meet qualifying factors)
Liver Specialists
We Thrive to cure liver Diseases
We would love to be part of your patients' journey...
Our Mission
Our mission is to provide state-of-the-art, innovative, and compassionate care to patients affected by liver diseases.
To achieve these goals we are committed to provide:
-
Outstanding, personalized patient care
-
Access to clinical liver research regarding the causes, prevention and treatment of liver diseases
-
Excellence in teaching and training clinicians and scientists in patient care and research in liver disease
Our facility was designed to accommodate our cutting edge diagnostic tools, chronic disease care and clinical trails of novel therapeutics for patients with various liver diseases.
Come in today to learn more about your liver and options for treatment of liver disease.
1 in 3 Americans
have Non-Alcoholic Fatty Liver Disease (NAFLD) or Non-Alcoholic Steatohepatitis (NASH)
…and many of them may not know it.
Meet Dr. Mazen Noureddin
Mazen Noureddin, MD, MHSc
Medical Director
“Life isn't about finding yourself. Life is about creating yourself.”
Mazen Noureddin, MD, MHSc, was the founding director of the Fatty Liver Program at Cedars-Sinai Medical Center (currently ranked #2 in GI and GI surgery per US News). He recently relocated to Texas from California to establish a state-of-the-art Houston Research Institute. Dr. Noureddin did his internal medicine residency at the University of Southern California (USC) and then moved to the National Institutes of Health (NIH), where he enrolled in a three-year hepatology fellowship at the Liver Diseases Branch of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). There, he finished the NIH/Duke University Master of Health Sciences in Clinical Research program. After completing his NIH fellowship, he completed a gastroenterology fellowship at the University of California, San Diego (UCSD), where he was a T32 NIH fellow. He then joined the University of Southern California (USC) as an Assistant Professor of Clinical Medicine in 2013. He was then recruited to Cedars-Sinai Medical Center in 2015 to establish its new fatty liver program.
Dr. Noureddin is internationally known for his research in the area of NAFLD/NASH and NASH related cirrhosis. He conducted more than 40 investigational clinical studies of novel treatments for NASH. He is an expert in non-invasive testing and biomarkers of NASH and cirrhosis. He has published in all these areas and has been invited to consensus panels on these topics by multiple international societies including the American Association for the Study of Liver Diseases (AASLD) and European Association for the Study of Liver Diseases (EASL). He has given invited lectures on NAFLD/NASH at national and international society meetings and serves on several steering committees/advisory boards for industry. He is the vice chair of the AASLD NASH special interest group (will be chairing the group in 2023) and serves on the editorial board for major GI journals including “Gastroenterology”, “Hepatology” and “Clinical Gastroenterology and Hepatology (CGH)”. He is one of the new Associate Editors of “Clinical Gastroenterology and Hepatology (CGH)”. He is funded by the National Cancer Institute and has served as a reviewer on NIH study sections. Dr. Noureddin has published in many journals including: The Lancet, Science Trinational Medicine, Journal of Hepatology, Journal of Clinical Investigation, Gastroenterology, Hepatology, Clinical Gastroenterology and Hepatology and others
Areas of Expertise
non-alcoholic fatty liver disease (NAFLD)
non-alcoholic steatohepatitis (NASH)
Hepatitis A
Hepatitis B
Hepatitis C
Autoimmune Hepatitis
Primary Biliary Cholangitis (PBC)
Primary Sclerosing Cholangitis (PSC)
Cirrhosis and Portal Hypertension
Esophageal Varices
Rare Liver Diseases
Liver Transplantation
Other Liver Conditions
Ask us about concierge hepatology
Call us today at 281 809 3234
